Impact of obesity on antiretroviral pharmacokinetics and immuno-virological response in HIV-infected patients: a case–control study | Zendy

Vincent Madelain | Zendy; Minh Patrick Lê | Zendy; Karen Champenois | Zendy; Charlotte Charpentier | Zendy; Roland Landman | Zendy; Véronique Joly | Zendy; Patrick Yéni | Zendy; Diane Descamps | Zendy; Yazdan Yazdanpanah | Zendy; Gilles Peytavin | Zendy

Open Access

Impact of obesity on antiretroviral pharmacokinetics and immuno-virological response in HIV-infected patients: a case–control study

Author(s) -

Vincent Madelain,

Minh Patrick Lê,

Karen Champenois,

Charlotte Charpentier,

Roland Landman,

Véronique Joly,

Patrick Yéni,

Diane Descamps,

Yazdan Yazdanpanah,

Gilles Peytavin

Publication year - 2016

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkw527

Subject(s) - pharmacokinetics , medicine , antiretroviral drug , human immunodeficiency virus (hiv) , obesity , antiretroviral therapy , virology , viral load , immunology

Obesity has high prevalence among HIV-infected patients. Increased adipose tissue mass affects the pharmacokinetics of numerous drugs, but few data are available for antiretroviral drugs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research